Ignite Creation Date:
2024-05-06 @ 7:55 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06180278
Status:
RECRUITING
Last Update Posted:
2024-05-13
First Post:
2023-11-17
Brief Title:
Long-term Open-label Safety Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorder NMOSD
Sponsor:
Amgen
Organization:
Amgen